These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12590236)

  • 1. Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage.
    Papi C; Gili L; Tarquini M; Antonelli G; Capurso L
    J Clin Gastroenterol; 2003 Mar; 36(3):238-41. PubMed ID: 12590236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility of infliximab therapy in severe enterorrhagia associated with Crohn's disease. Report of three cases].
    Alcalde Vargas A; Justiniano JM; Carnerero EL; Salado CT; Domingo IG; Galán JL
    Gastroenterol Hepatol; 2011 Jan; 34(1):24-8. PubMed ID: 21168243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn's disease.
    Kim KJ; Han BJ; Yang SK; Na SY; Park SK; Boo SJ; Park SH; Yang DH; Park JH; Jeong KW; Ye BD; Byeon JS; Myung SJ; Kim JH
    Dig Liver Dis; 2012 Sep; 44(9):723-8. PubMed ID: 22497905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for severe gastrointestinal bleeding in Crohn's disease.
    Ando Y; Matsushita M; Kawamata S; Shimatani M; Fujii T; Okazaki K
    Inflamm Bowel Dis; 2009 Mar; 15(3):483-4. PubMed ID: 18668673
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximab.
    Belaiche J; Louis E
    Am J Gastroenterol; 2002 Dec; 97(12):3210-1. PubMed ID: 12492221
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab stopped severe gastrointestinal bleeding in Crohn's disease.
    Aniwan S; Eakpongpaisit S; Imraporn B; Amornsawadwatana S; Rerknimitr R
    World J Gastroenterol; 2012 Jun; 18(21):2730-4. PubMed ID: 22690085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease.
    Tsujikawa T; Nezu R; Andoh A; Saotome T; Araki Y; Ishizuka Y; Sasaki M; Koyama S; Fujiyama Y
    J Gastroenterol; 2004; 39(3):284-7. PubMed ID: 15065007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab treatment of massive upper gastrointestinal bleeding in gastroduodenal Crohn's disease.
    Kocaman O; Aygün C; Konduk T; Celebi A; Sentürk O; Hülagü S
    Turk J Gastroenterol; 2008 Sep; 19(3):197-8. PubMed ID: 19115158
    [No Abstract]   [Full Text] [Related]  

  • 10. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
    Geboes K; Rutgeerts P; Opdenakker G; Olson A; Patel K; Wagner CL; Marano CW
    Curr Med Res Opin; 2005 Nov; 21(11):1741-54. PubMed ID: 16307694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab therapy for Crohn's-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report.
    Akazawa Y; Takeshima F; Yajima H; Imanishi D; Kanda T; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Hayashi T; Nakashima M; Nakao K
    BMC Res Notes; 2014 Jun; 7():382. PubMed ID: 24952714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease.
    Shen W; Cao L; Li Y; Cai X; Ge Y; Zhu W
    Dis Colon Rectum; 2018 Jun; 61(6):706-712. PubMed ID: 29722729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infliximab treatment of severe bleeding complicating Crohn's disease].
    Julián Gómez L; Atienza R; Barrio J; Gil P; Gómez de la Cuesta S; Pinto P; Alcaide N; Caro Patón A
    Rev Esp Enferm Dig; 2010 Jan; 102(1):57-8. PubMed ID: 20187687
    [No Abstract]   [Full Text] [Related]  

  • 16. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
    Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemorrhagic Crohn's disease controlled with infliximab.
    Meyer MM; Levine EJ
    Inflamm Bowel Dis; 2009 Oct; 15(10):1456-7. PubMed ID: 19107774
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.
    Di Sabatino A; Ciccocioppo R; Cinque B; Millimaggi D; Morera R; Ricevuti L; Cifone MG; Corazza GR
    Gut; 2004 Jan; 53(1):70-7. PubMed ID: 14684579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group.
    Belaiche J; Louis E; D'Haens G; Cabooter M; Naegels S; De Vos M; Fontaine F; Schurmans P; Baert F; De Reuck M; Fiasse R; Holvoet J; Schmit A; Van Outryve M
    Am J Gastroenterol; 1999 Aug; 94(8):2177-81. PubMed ID: 10445546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.